Beta Amyloid, Tau Protein, and Neuroinflammation: An Attempt to Integrate Different Hypotheses of Alzheimer’s Disease Pathogenesis
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 55 (5) , 670-682
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disease that inevitably results in dementia and death. Currently, there are no pathogenetically grounded methods for the prevention and treatment of AD, and all current treatment regimens are symptomatic and unable to significantly delay the development of dementia. The accumulation of β-amyloid peptide (Aβ), which is a spontaneous, aggregation-prone, and neurotoxic product of the processing of signaling protein APP (Amyloid Precursor Protein), in brain tissues, primarily in the hippocampus and the frontal cortex, was for a long time considered the main cause of neurodegenerative changes in AD. However, attempts to treat AD based on decreasing Aβ production and aggregation did not bring significant clinical results. More and more arguments are arising in favor of the fact that the overproduction of Aβ in most cases of AD is not the initial cause, but a concomitant event of pathological processes in the course of the development of sporadic AD. The concept of neuroinflammation has come to the fore, suggesting that inflammatory responses play the leading role in the initiation and development of AD, both in brain tissue and in the periphery. The hypothesis about the key role of neuroinflammation in the pathogenesis of AD opens up new opportunities in the search for ways to treat and prevent this socially significant disease.Keywords
This publication has 138 references indexed in Scilit:
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementiaJournal of Neural Transmission, 2012
- A Review: Inflammatory Process in Alzheimer's Disease, Role of CytokinesThe Scientific World Journal, 2012
- Recombinant human Hsp70 protects against lipoteichoic acid-induced inflammation manifestations at the cellular and organismal levelsCell Stress and Chaperones, 2012
- Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-AmyloidosisScience, 2010
- Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenalExperimental Neurology, 2008
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behaviorBehavioural Brain Research, 2008
- Mechanisms for Hsp70 secretion: Crossing membranes without a leaderMethods, 2007
- Role of toll-like receptor signalling in A uptake and clearanceBrain, 2006